Increased isolation of Vibrio cholerae O1 serotype Inaba over serotype Ogawa in Pakistan

Eastern Mediterranean Health Journal

Volumn 14, Issue 3, 2008, Pages 564-570

  Jabeen, Kausar ^a   Zafar, A ^a   Hasan, R ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; COTRIMOXAZOLE; OFLOXACIN; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; FECES ANALYSIS; HUMAN; NONHUMAN; PAKISTAN; SEROTYPE; VIBRIO CHOLERAE;

ADULT; AGE DISTRIBUTION; CHOLERA; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENDEMIC DISEASES; EPIDEMIOLOGY, MOLECULAR; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; PAKISTAN; POPULATION SURVEILLANCE; SEROTYPING; VIBRIO CHOLERAE O1;

EID: 48249131704     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sack AD et al. Cholera. Lancet, 2004, 363:223-33.
2. Colwell RR et al. Serogroup conversion of Vibrio cholerae. Canadian journal of microbiology, 1995, 41:946-50.
3. Jabeen K, Hasan R. Re-emergence of Vibrio cholerae O139 in Pakistan: report from a tertiary care hospital. Journal of the Pakistan Medical Association, 2003, 53:335-58.
4. Alam M et al. Seasonal variation in bacterial pathogens isolated from stool samples in Karachi, Pakistan. Journal of the Pakistan Medical Association, 2003, 53:125-9.
5. Nizami S, Farooqui B. Cholera in children in Karachi from 1990 through 1995: a study of cases admitted to a tertiary care hospital. Journal of the Pakistan Medical Association, 1998, 48:171-3.
6. Das S et al. Fluroquinolone resistance in Vibrio cholerae O1: emergence of El Tor Inaba. Annals of tropical paediatrics, 2005, 25:211-2.
7. Taneja N et al. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba in north India. Japanese journal of infectious diseases, 2005, 58:238-40.
8. Koneman EW et al. Color atlas and text book of diagnostic microbiology, 5th ed. Philadelphia, Lippincott, 1997.
9. Performance standards for antimicrobial susceptibility testing. 15th informational supplement. Volume 25(1). Wayne, Pennsylvania, Clinical and Laboratory Standards Institute, 2005.
10. Ramamurthy T et al. Serovar, biotype, phage type, toxigenicity and antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta. Indian journal of medical research, 1992, 95:125-9.
11. Swerdlow DL et al. Epidemic cholera among refugees in Malawi, Africa: treatment and transmission. Epidemiology and infection, 1997, 118:207-14.
12. Finelli L et al. Outbreak of cholera associated with crab brought from an area with epidemic disease. Journal of infectious diseases, 1992, 166:1433-5.
13. Kam KM et al. Outbreak of Vibrio cholerae 01 in Hong Kong related to contaminated fish tank water. Public health, 1995, 109:389-95.
14. Saha PK et al. Nontoxigenic Vibrio cholerae 01 serotype Inaba biotype El Tor associated with a cluster of cases of cholera in southern India. Journal of clinical microbiology, 1996; 34:1114-7.
15. Swaddiwudhipong W, Kunasol P. An outbreak of nosocomial cholera in a 755-bed hospital. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1989, 83:279-81.
16. Waldor MK, Tschäpe H, Mekalanos JJ. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim and streptomycin in Vibrio cholerae O139. Journal of bacteriology, 1996, 178:4157-65.
17. Garg P et al. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba from the prevailing O1 Ogawa serotype strains in India. Journal of clinical microbiology, 2000, 38:4249-53.